Cardiology

Inhibiting ApoC-III reduces triglyceride levels in mice

Some individuals remain at high risk for developing cardiovascular disease even after preventative treatment with cholesterol-lowering medications. This persistent risk has been linked to triglyceride levels, which can remain ...

Medications

Evolocumab: No hint of added benefit

Evolocumab (trade name: Repatha) has been approved since July 2015 for two therapeutic indications: on the one hand, for hypercholesterolaemia or mixed dyslipidaemia, and on the other, for homozygous familial hypercholesterolaemia. ...

Health

Letter from doctor boosts cholesterol medication use

In a new study, Northwestern Medicine researchers found that patients at high risk for cardiovascular disease (CVD) are more likely to receive a prescription for cholesterol-lowering medication, and to achieve lower long-term ...

Health

Obama 'fit at fifty': medical report

US President Barack Obama is "fit at fifty" after improving his cholesterol readings and kicking his smoking habit, according to results of his latest medical exam released Monday.

page 16 from 17